SUNNYVALE, Calif., Oct. 28 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that Bob Wong has returned to Accuray as General Manager of the APAC (Asia Pacific, including Australia but excluding India and Japan) region effective October 14, 2010.
Wong previously served as Managing Director of Accuray’s APAC region from 2005 to 2008. During that time, Wong helped build Accuray’s operation in the APAC region and successfully lead sales initiatives. After leaving Accuray, Wong remained active in the medical field and held various business leadership positions both at IMRIS Inc. and Haemonetics.
“We are happy to welcome Bob Wong back to Accuray. Wong’s more than 26 years of work experience with 20 years in the medical capital equipment business along with his network of industry contacts in the APAC region and successful sales track record, will make him an asset to Accuray’s APAC operations,” said Euan S. Thomson, Ph.D., president and chief executive officer of Accuray Incorporated. “The APAC region already accounts for more than 10 percent of Accuray’s installation base. Under Wong’s leadership, Accuray is well-positioned to continue growing its global footprint.”
Wong will report to Accuray’s president and chief executive officer, Euan Thomson, and will be fully responsible for leading sales, service and marketing for the APAC region.
Presently there are 24 CyberKnife Systems installed throughout the APAC region.
About the CyberKnife® Robotic Radiosurgery System
The CyberKnife Robotic Radiosurgery System is the world’s only robotic radiosurgery system designed to treat tumors anywhere in the body non-invasively. Using continual image guidance technology and computer controlled robotic mobility, the CyberKnife System automatically tracks, detects and corrects for tumor and patient movement in real-time throughout the treatment. This enables the CyberKnife System to deliver high-dose radiation with pinpoint precision, which minimizes damage to surrounding healthy tissue and eliminates the need for invasive head or body stabilization frames.
About Accuray
Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends the benefits of radiosurgery to include extracranial tumors, including those in the spine, lung, prostate, liver and pancreas. To date, the CyberKnife System has been used to deliver more than 100,000 treatments worldwide and more than 206 systems have been installed in leading hospitals in the Americas, Europe and Asia. For more information, please visit www.accuray.com.
Safe Harbor Statement
The foregoing may contain certain forward-looking statements that involve risks and uncertainties, including uncertainties associated with the medical device industry. Except for the historical information contained herein, the matters set forth in this press release, including statements relating to management experience and clinical adoption are forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements speak only as of the date the statements are made and are based on information available at the time those statements are made and/or management’s good faith belief as of that time with respect to future events. You should not put undue reliance on any forward-looking statements. Important factors that could cause actual performance and results to differ materially from the forward-looking statements we make include: market acceptance of products; competing products, the combination of our products with complementary technology; and other risks detailed from time to time under the heading “Risk Factors” in our report on Form 10-K for the 2010 fiscal year which has been filed with the Securities and Exchange Commission on August 31, 2010. The Company’s actual results of operations may differ significantly from those contemplated by such forward-looking statements as a result of these and other factors. We assume no obligation to update forward-looking statements to reflect actual performance or results, changes in assumptions or changes in other factors affecting forward-looking information, except to the extent required by applicable securities laws.
SOURCE Accuray Incorporated
